Search research articles
Contact Us
Filters
Showing results (41-50 of 66) with videos related to
Page
of 7
Sort By:
Cancer Research
|
January 21, 2006
Elevated expression of ISG15 in tumor cells interferes with the ubiquitin/26S proteasome pathway
Shyamal D Desai, Arthur L Haas, Laurence M Wood, et al.
Cancer
|
February 2, 2012
A phase 1 trial of E7974 administered on day 1 of a 21-day cycle in patients with advanced solid tumors
Caio M Rocha-Lima, Soley Bayraktar, Jessica Macintyre, et al.
Cancer Chemotherapy and Pharmacology
|
November 30, 2013
E5501: phase II study of topotecan sequenced with etoposide/cisplatin, and irinotecan/cisplatin sequenced with etoposide for extensive-stage small-cell lung cancer
Taofeek K Owonikoko, Joseph Aisner, Xin Victoria Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 31, 2019
Challenges with Novel Clinical Trial Designs: Master Protocols
Michael Cecchini, Eric H Rubin, Gideon M Blumenthal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 6, 2009
A single supratherapeutic dose of vorinostat does not prolong the QTc interval in patients with advanced cancer
Pamela N Munster, Eric H Rubin, Simon Van Belle, et al.
Anti-Cancer Drugs
|
May 6, 2008
Sequential topoisomerase targeting and analysis of mechanisms of resistance to topotecan in patients with acute myelogenous leukemia
Biren Saraiya, Murugesan Gounder, Jayeeta Dutta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 17, 2008
Pharmacokinetic/pharmacodynamic modeling and simulation of neutropenia during phase I development of liposome-entrapped paclitaxel
Gerald J Fetterly, Thaddeus H Grasela, Jeffrey W Sherman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 14, 2002
Selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 is generally well-tolerated and has activity in non-small-cell lung cancer and other solid tumors: results of a phase I trial
Roy S Herbst, Anne-Marie Maddox, Mace L Rothenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 6, 2006
A study to determine the effects of food and multiple dosing on the pharmacokinetics of vorinostat given orally to patients with advanced cancer
Eric H Rubin, Nancy G B Agrawal, Evan J Friedman, et al.
Cancer Chemotherapy and Pharmacology
|
October 19, 2005
A phase I clinical trial of 12- O-tetradecanoylphorbol-13-acetate for patients with relapsed/refractory malignancies
Dale Schaar, Lauri Goodell, Joseph Aisner, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 66) with videos related to
Sort By:
Page
of 7
Cancer Research
|
January 21, 2006
Elevated expression of ISG15 in tumor cells interferes with the ubiquitin/26S proteasome pathway
Shyamal D Desai, Arthur L Haas, Laurence M Wood, et al.
Cancer
|
February 2, 2012
A phase 1 trial of E7974 administered on day 1 of a 21-day cycle in patients with advanced solid tumors
Caio M Rocha-Lima, Soley Bayraktar, Jessica Macintyre, et al.
Cancer Chemotherapy and Pharmacology
|
November 30, 2013
E5501: phase II study of topotecan sequenced with etoposide/cisplatin, and irinotecan/cisplatin sequenced with etoposide for extensive-stage small-cell lung cancer
Taofeek K Owonikoko, Joseph Aisner, Xin Victoria Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 31, 2019
Challenges with Novel Clinical Trial Designs: Master Protocols
Michael Cecchini, Eric H Rubin, Gideon M Blumenthal, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 6, 2009
A single supratherapeutic dose of vorinostat does not prolong the QTc interval in patients with advanced cancer
Pamela N Munster, Eric H Rubin, Simon Van Belle, et al.
Anti-Cancer Drugs
|
May 6, 2008
Sequential topoisomerase targeting and analysis of mechanisms of resistance to topotecan in patients with acute myelogenous leukemia
Biren Saraiya, Murugesan Gounder, Jayeeta Dutta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 17, 2008
Pharmacokinetic/pharmacodynamic modeling and simulation of neutropenia during phase I development of liposome-entrapped paclitaxel
Gerald J Fetterly, Thaddeus H Grasela, Jeffrey W Sherman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 14, 2002
Selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 is generally well-tolerated and has activity in non-small-cell lung cancer and other solid tumors: results of a phase I trial
Roy S Herbst, Anne-Marie Maddox, Mace L Rothenberg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 6, 2006
A study to determine the effects of food and multiple dosing on the pharmacokinetics of vorinostat given orally to patients with advanced cancer
Eric H Rubin, Nancy G B Agrawal, Evan J Friedman, et al.
Cancer Chemotherapy and Pharmacology
|
October 19, 2005
A phase I clinical trial of 12- O-tetradecanoylphorbol-13-acetate for patients with relapsed/refractory malignancies
Dale Schaar, Lauri Goodell, Joseph Aisner, et al.
Page
of 7